Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Experts At European Parliament Session Outline Challenges In TB Drug Development

EurActiv: Developing countries urged to produce TB vaccines locally “Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease. Speaking at the European Parliament on Wednesday (21…

Asia’s Largest Vaccine Maker Developing Low-Cost HPV, Diarrheal, Pneumococcal Vaccines

Bloomberg Businessweek: Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health “…Serum Institute of India Ltd., which makes vaccines injected in 65 percent of the world’s children, is targeting newer vaccines, including one for the human papillomavirus that could be available in late 2018 and sell at a third of…

Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases Roger Bate, scholar at the American Enterprise Institute “…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance…

South African Health Minister Says TB Is Biggest Threat To Mining Industry Workers

“Accidents and violence get most of the attention, but the deadliest threat to workers in the South African mining industry is tuberculosis, says the minister of health leading new efforts to combat the infectious disease,” The Star reports. Summarizing an interview with South African Health Minister Aaron Motsoaledi, who was…

Partnerships Under MPP Key To Lowering Antiretroviral Therapy Costs

The ONE blog features an interview with Esteban Burrone, head of policy for the Medicines Patent Pool, who discusses how antiretroviral drugs used to treat HIV became less expensive over the past decade, allowing for millions more people living with the virus to receive treatment. Burrone says partnerships with pharmaceutical…

Former Pharmaceutical Executive Speaks About Vaccine Development, Distribution

In partnership with the Skoll World Forum, Forbes features an interview with Kevin Reilly, former president of the vaccines and nutrition division of Wyeth Pharmaceuticals, who discusses the challenges of vaccine development and distribution. “Increasingly, I see pharmaceutical and vaccine manufacturers engaging in the dialogue about strengthening immunization and distribution…

Skoll World Forum ‘Debate & Series’ Examines Health-Related MDGs

“In the lead up to the U.N. General Assembly, the Skoll World Forum┬ápartnered with Johnson & Johnson, the United Nations Foundation and the Bill & Melinda Gates Foundation to produce an online debate focused on the last 850 days before the [Millennium Development Goals (MDGs)] expire in 2015,” the “Debate…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.